BRONCHO-VAXOM ADULT 10 CAP

* Broncho-vaxom Adults. Polyvalent immunobiotherapy for the respiratory system.
* Composition:
7 mg lysat. bacter. lyophilisat. (Haemophilus influenzae, Diplococcus pneumoniae,
Klebsiella pneuminiae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes
and viridans, Neisseria catarrhalis).
* Indications:
Adjuvant therapy in all infections of the respiratory system and of the ears, nose, or throat.
Prevention of recurrences and of transition of the chronic state.
BRONCHO-VAXOM is especially recommended as adjuvant therapy in:
– Acute and chronic bronchitis.
– Sore throat, tonsillitis, pharyngitis, and laryngitis.
– Rhinitis sinusitis and otitis.
– Infections resistant to conventional antibiotics.
– Bacterial complications of viral infections of the respiratory system. especially in children and the elderly.
* Tolerance:
Excellent There, are no contraindications. No allergic reactions have been reported.
* Dosage:
Treatment of acute episode; one capsule daily on an empty stomach until the symptoms disappear.
but for not, less than 10 days. In cases in which antibiotics are needed. BRONCHO-VAXOM Should be
given in addition to the antibiotic right from the start of therapy.
Consolidation therapy one capsule daily on 10 consecutive days per month for three months.
* Protect from heat (15-25 degrees C)